Safehouse, the nonprofit group launching the site, made the announcement just hours after a federal judge submitted a final ruling that the site does not violate federal law.
Federal prosecutors filed a civil lawsuit against Safehouse in February 2019, attempting to block the group’s attempt to open the supervised injection site. Prosecutors alleged that the site would violate a provision in the Controlled Substances Act that makes it a felony to knowingly open, lease or maintain any location for the purpose of distributing or using controlled substances.
However, in a preliminary ruling last October, U.S. District Judge Gerald McHugh ruled that the Controlled Substances Act does not apply to Safehouse’s efforts to aid individuals with opioid use disorder.
The supervised injection site will allow people to use illegal drugs under medical supervision, access treatment and be revived if they overdose.
To view the full report, click here.
More articles on opioids:
Ohio county considers adding 2nd morgue for surge in opioid overdose deaths
Medicaid expansion linked to drop in opioid overdose deaths
How Houston Methodist reduced opioid prescriptions by nearly 77%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
